BrianTempest Presentation IndoJapanFeb07

Information about BrianTempest Presentation IndoJapanFeb07

Published on April 14, 2008

Author: funnyside

Source: authorstream.com

Content

Succeeding in Japan :  Succeeding in Japan Dr. Brian W Tempest Chief Mentor & Executive Vice Chairman of the Board Ranbaxy Laboratories Limited, Delhi, India India Japan Initiative Mumbai – 2nd February 2007 Disclaimer:  Except for the historical information contained herein, statements in this presentation and the subsequent discussions, which include words or phrases such as “will”, “aim”, “will likely result”, “would”, “believe”, “may”, “expect”, “will continue”, “anticipate”, “estimate”, “intend”, “plan”, “contemplate”, “seek to”, “future”, “objective”, “goal”, “likely”, “project”, “should”, “potential”, “will pursue” and similar expressions or variations of such expressions may constitute "forward-looking statements". These forward-looking statements involve a number of risks, uncertainties and other factors that could cause actual results to differ materially from those suggested by the forward-looking statements. These risks and uncertainties include, but are not limited to our ability to successfully implement our strategy, our growth and expansion plans, obtain regulatory approvals, our provisioning policies, technological changes, investment and business income, cash flow projections, our exposure to market risks as well as other risks. Ranbaxy does not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date thereof. Disclaimer Slide3:  Where is the World’s Wealth? Cannada 2% Rest of World 10% Japan 27% Germany 4% Italy 4% France 5% UK 6% USA 37% Netherlands 2% Spain 1% Switzerland 1% Taiwan 1% Source: The World Distribution of Household Wealth Slide4:  Where are the Worlds’ Pharmaceuticals sold? Top 15 countries = 85.9% of worldwide pharmaceutical market estimate 2003 2.4% 3.3% 3.4% 4.9% 5.4% 12.0% 44.6% 1.5% 1.5% 2.0% Japan’s GDP:  Japan’s GDP A race to prosperity:  A race to prosperity Indo - Japan Political & Economic Background:  Indo - Japan Political & Economic Background Japan Recovering from a decade old recession Japan is fully exposed to China, but now there is a political inpasse JETRO, Abe, Koizumi – all giving positive guidance on India Ageing is a major issue in Japan - by 2050 36% > 65 years from 19% in 2005 Huge interest with many Japanese delegations visiting India Japanese Government Policy changes on Pharmaceuticals:  Japanese Government Policy changes on Pharmaceuticals Past - Poor quality, poor support 2002 - National hospitals start using generics 2003 - Co-payments begin at 30% 2004 - Public hospitals become companies 2006 - GPs can opt for generic substitution Postal worker challenge helped minimize the influence of the doctor lobby Japanese Government Intervention on Pharmaceuticals:  Japanese Government Intervention on Pharmaceuticals Global Size Companies 4 companies of global size Fugisawa + Yamanouchi = Astellas (April’06) Sankyo + Daiichi Takeda Eisai Mid Size Companies Move to niches and/or generics Shionogi Tanabe Mitsubishi Slide10:  Both Japan & India are hungry for Information China 123 m Japan 86 m India 51 m S.Korea 34 m Source: Business Today, Sept. 24, 2006 China 421 m 2. USA 190 m Japan 157 m Russia 148 m 5. India 116 m Source: Times of India, Sept. 14, 2006 Internet Usage – Asia Mobile Phones Japanese – India differences:  Japanese – India differences Before time vs After time Open neck shirt vs White shirts/ties Sashime vs Vegetarianism Golf vs Cricket Takes time for each side to understand what is a very complex picture, eg. visiting cards, hellos Japanese are heavily influenced by USA, Technology Innovation, Productivity & Education Slide13:  - One in every four ANDAs filed by Indian Companies in top USA FDA filers Source: KPMG - No Chinese generic company has yet filed a USA FDA ANDA The Pharma Advantage - ANDAs 24 46 64 144 ANDA Filings in USA by Indian Companies Slide14:  The Pharma Advantage – API’s USA DMF filings by India 1990 1 1995 4 2000 36 2004 187 2005 262 Source: Crisil / US FDA / J P Morgan % Share of USA DMF filings India China 2004 27% 9% 2005 37% 10% Q1’06 44% 15% Q2’06 41% 16% Q3’06 45% 17% (latest) Source: US FDA / J P Morgan, 6th August 2006 Source: US FDA, Credit Suisse Slide15:  Number of Higher Education Institutions 05/06 18,123 +59% 00/01 11,412 90/01 5,932 80/01 4,861 Source: Indian University Grants Commission Science Education in India Number of Students enrolled in Higher Education Institutions 05/06 10,500 +40% 00/01 7,500 90/01 4,000 80/01 3,000 Source: Indian University Grants Commission Number of Institutions courses 05/06 99/00 Pharmacy 1478 669 +120% Medicine 229 174 +32% Physiotherapy 205 52 +294% Source: Pavan Agarwal (2006) based on data from professional councils PhD Degree awarded in Science 03/04 5408 +44% 00/01 3734 90/01 2950 (USA 03/04 25,000) Source: Indian University Grants Committee Slide16:  The Education Advantage Engineers/Science graduates p.a – India 0.7m, China 0.5m, EU 0.5m, USA 0.4m, Japan 0.3m The R&D Investment Advantage:  The R&D Investment Advantage Most attractive R&D Investment locations: Ranked 3rd - China, USA, India, Japan & UK Source – UNCTAD 2005 Reasons why India: Qualified Scientists & Engineers Global India players with Alliances English speaking TRIPs compliant – first patent March 2006 IIT, IIM & other scientific institutions Source – UNCTAD 2005 Slide18:  The Productivity Advantage Sources: IPHMR Conferences, New Delhi August 2004 Global Market Trends – Discovery R&D:  Global Market Trends – Discovery R&D Vendor Availability India China Analog preparation 41 25 Combinatorial chemistry 37 7 Analytical chemistry 37 7 Structural chemistry 26 5 Assay development 26 2 Computer drug design 26 13 High throughput Screening 11 2 Bio informatics 13 7 Genetically modified animals 0 3 Basic molecular biology 13 25 Source – BCG, ‘Looking Eastwards, September 2006’ *Out of 90 vendors in October 2005 Global Market Trends for Generic Companies:  Global Market Trends for Generic Companies Source: UBS, Businessworld, 30th October 2006 The Japanese generic market:  The Japanese generic market $2.0b in 2006 with a 5% level of generic substitution Forecast to increase by 11% p.a to 2010 Novartis has a 5% share – leading foreign generic player Regular price reductions (related to trade discounts) Slide22:  Source: JP Morgan Asia Pacific, Equity Research 16 November 2005 Nippon Chemipher Generics Business 4.3 5.4 6.2 8.5 7.3 10.00 11.50 Yen billion Slide23:  Experience Worked on our relationship for several years since 2003 50% in joint venture Filed products to meet expectations of MHLW Manufactured products to Japanese Consumer expectations Now launched several products with our partner Leading market share of products launched Constant Interaction with Japanese investors & media Reputation Licence in opportunities for India/China from Japan Manufacturing contracts for Japan NCEs intermediates Our story in Japan M&A deals in Europe by Indian Companies 2003 - 2007:  M&A deals in Europe by Indian Companies 2003 - 2007 Company Number Ranbaxy 6 Wockhardt 3 Stada 2 Matrix 2 DRL 1 Aurobindo 1 Torrent 1 Sun Pharma 1 Jubiliant 1 Zydu Cadilla 1 _______________________________________________ Total 19 _______________________________________________ Source: Nomura, December 2006 Conclusion:  Conclusion Huge business potential opportunity Good fit & Synergy between India & Japan Long term planning needed Personal attention of the CEO required on the relationship Accept the complexity and may not understand everything Focus on technology innovation, USA, education, productivity Slide26:  Thank You

Related presentations


Other presentations created by funnyside

HCM Luzern
18. 06. 2007
0 views

HCM Luzern

lecture12
12. 10. 2007
0 views

lecture12

basketball
01. 08. 2007
0 views

basketball

Atacama Large Millimeter Array
15. 06. 2007
0 views

Atacama Large Millimeter Array

gen mtgmar07 slides
18. 06. 2007
0 views

gen mtgmar07 slides

THAKKAR ANJALI artificial blood
16. 10. 2007
0 views

THAKKAR ANJALI artificial blood

20030815 RepICFA HN
27. 09. 2007
0 views

20030815 RepICFA HN

Owen
03. 10. 2007
0 views

Owen

14BBlackHoles
07. 10. 2007
0 views

14BBlackHoles

Noda06
09. 10. 2007
0 views

Noda06

reptile
10. 10. 2007
0 views

reptile

leskov
15. 10. 2007
0 views

leskov

461
17. 10. 2007
0 views

461

Europe Presentation
19. 10. 2007
0 views

Europe Presentation

RadOnc
22. 10. 2007
0 views

RadOnc

schnittsysteme
23. 10. 2007
0 views

schnittsysteme

ch1 10 part2
23. 10. 2007
0 views

ch1 10 part2

firma end Presentation
19. 10. 2007
0 views

firma end Presentation

sta291 5c
29. 10. 2007
0 views

sta291 5c

ACM India Studies 2005
26. 11. 2007
0 views

ACM India Studies 2005

Mirabel
01. 12. 2007
0 views

Mirabel

ghana
10. 12. 2007
0 views

ghana

DanishCitationEventJB final
15. 10. 2007
0 views

DanishCitationEventJB final

aleynikov
26. 10. 2007
0 views

aleynikov

ShortageChicago Seago 2
29. 10. 2007
0 views

ShortageChicago Seago 2

Daylight Saving Time
07. 11. 2007
0 views

Daylight Saving Time

unity
21. 08. 2007
0 views

unity

Fad Diets
21. 08. 2007
0 views

Fad Diets

NACADA Combined Workshop
21. 08. 2007
0 views

NACADA Combined Workshop

TeraGrid SC06 1
22. 10. 2007
0 views

TeraGrid SC06 1

plane parallel 2 1
24. 10. 2007
0 views

plane parallel 2 1

cronologia storia contemporanea
13. 11. 2007
0 views

cronologia storia contemporanea

IDitarod
16. 11. 2007
0 views

IDitarod

Axiome Von Neumann Morgenstern
19. 11. 2007
0 views

Axiome Von Neumann Morgenstern

Dog bite sepsis
19. 11. 2007
0 views

Dog bite sepsis

Girish
21. 11. 2007
0 views

Girish

EcoValidity
17. 12. 2007
0 views

EcoValidity

matthew
29. 12. 2007
0 views

matthew

Cyatheaceae Classification
02. 01. 2008
0 views

Cyatheaceae Classification

RFF Shinnecock
03. 01. 2008
0 views

RFF Shinnecock

AustralianPoetry
03. 01. 2008
0 views

AustralianPoetry

dbl dutch
22. 11. 2007
0 views

dbl dutch

Lecture10 overheads
21. 08. 2007
0 views

Lecture10 overheads

Deborah Russell Presentation
14. 11. 2007
0 views

Deborah Russell Presentation

AAPT v3
01. 08. 2007
0 views

AAPT v3

EScannapieco
15. 11. 2007
0 views

EScannapieco

Successful  Case  Studies
29. 09. 2007
0 views

Successful Case Studies

Interv Hajji
23. 10. 2007
0 views

Interv Hajji

khelif edson rep
09. 10. 2007
0 views

khelif edson rep

aadcrocodile
11. 10. 2007
0 views

aadcrocodile

matricole
16. 10. 2007
0 views

matricole

the three little pigs
14. 02. 2008
0 views

the three little pigs

Exon HKSB
30. 10. 2007
0 views

Exon HKSB

June06SPCCUpdateJVan voorhis
07. 11. 2007
0 views

June06SPCCUpdateJVan voorhis

cultural impact hispanics tn
24. 02. 2008
0 views

cultural impact hispanics tn

SE 05 Punctuation I
29. 02. 2008
0 views

SE 05 Punctuation I

GaryCorbett e
04. 03. 2008
0 views

GaryCorbett e

Radiation Hazards
06. 03. 2008
0 views

Radiation Hazards

Portoroz
04. 10. 2007
0 views

Portoroz

jdean c10
25. 03. 2008
0 views

jdean c10

SoS
25. 03. 2008
0 views

SoS

MVestergaard SantaFe06
29. 11. 2007
0 views

MVestergaard SantaFe06

PowerPointTour
02. 11. 2007
0 views

PowerPointTour

tal daly
10. 04. 2008
0 views

tal daly

matz011
16. 04. 2008
0 views

matz011

installaware faq
17. 04. 2008
0 views

installaware faq

ATMSELong
18. 04. 2008
0 views

ATMSELong

36329938
22. 04. 2008
0 views

36329938

ITCan
10. 03. 2008
0 views

ITCan

kejian4
11. 10. 2007
0 views

kejian4

061213 dialog north korea petrov
11. 10. 2007
0 views

061213 dialog north korea petrov

Session6 Adm Wilcocks
07. 11. 2007
0 views

Session6 Adm Wilcocks

high technology surgery
30. 04. 2008
0 views

high technology surgery

Robot Convoy final presentation
07. 01. 2008
0 views

Robot Convoy final presentation

harry truman
18. 06. 2007
0 views

harry truman

goldrush
18. 06. 2007
0 views

goldrush

GMK
18. 06. 2007
0 views

GMK

gatech
18. 06. 2007
0 views

gatech

fusion be
18. 06. 2007
0 views

fusion be

Fun Facts updated 3 05
18. 06. 2007
0 views

Fun Facts updated 3 05

Geomatic AAU 07032007 forkortet
18. 06. 2007
0 views

Geomatic AAU 07032007 forkortet

General Spring Intro
18. 06. 2007
0 views

General Spring Intro

intervento Ambrosi Legge125
18. 06. 2007
0 views

intervento Ambrosi Legge125

insostegno
18. 06. 2007
0 views

insostegno

Inhalts angabe
18. 06. 2007
0 views

Inhalts angabe

Implant Simulations
18. 06. 2007
0 views

Implant Simulations

implantate berlin
18. 06. 2007
0 views

implantate berlin

Imber stud
18. 06. 2007
0 views

Imber stud

hsm bend2
18. 06. 2007
0 views

hsm bend2

history mat storia dei diritti
18. 06. 2007
0 views

history mat storia dei diritti

headquarters structure
18. 06. 2007
0 views

headquarters structure

Department Of Conservation
23. 10. 2007
0 views

Department Of Conservation

Hippo
18. 07. 2008
0 views

Hippo

pa3 disare ppt
28. 09. 2007
0 views

pa3 disare ppt

Sudan Polio Update 03 05
21. 10. 2007
0 views

Sudan Polio Update 03 05

bradford ancer
21. 08. 2007
0 views

bradford ancer

Delaunay Triangulations
15. 06. 2007
0 views

Delaunay Triangulations

Bayesian analysis and problems
15. 06. 2007
0 views

Bayesian analysis and problems

Biofuels - Think Big
15. 06. 2007
0 views

Biofuels - Think Big

AVO  - Virtual Observatory
15. 06. 2007
0 views

AVO - Virtual Observatory

PHOBOS Collaboration
15. 06. 2007
0 views

PHOBOS Collaboration

gennaipm
18. 06. 2007
0 views

gennaipm

sigcse2003
07. 12. 2007
0 views

sigcse2003

Introductionto Kyrgyzstan
26. 11. 2007
0 views

Introductionto Kyrgyzstan

HIT SAN
18. 06. 2007
0 views

HIT SAN

Metzenbaum Shelley
23. 10. 2007
0 views

Metzenbaum Shelley

ppt CHAP018
24. 02. 2008
0 views

ppt CHAP018

lesson3 warm up
07. 04. 2008
0 views

lesson3 warm up

shelving with lcc
19. 02. 2008
0 views

shelving with lcc

25ConnectionsV5 p2
18. 10. 2007
0 views

25ConnectionsV5 p2

2506043
15. 11. 2007
0 views

2506043

TravelChapter7 3
27. 03. 2008
0 views

TravelChapter7 3

french rfp
18. 06. 2007
0 views

french rfp

BEFxii Coronado
09. 04. 2008
0 views

BEFxii Coronado

spectrumastrotalk
28. 11. 2007
0 views

spectrumastrotalk

metadata frames
05. 10. 2007
0 views

metadata frames

Dancefinal
27. 11. 2007
0 views

Dancefinal